
# SODIUM AND WATER HOMEOSTASIS

# OVERVIEW

## General (_NEJM_ 2015;372:55 & 373:1350)

• Disorders of serum sodium are generally due to Δs in _total body water_, not sodium

• Hyper- or hypo-osmolality → rapid water shifts → Δs in brain cell volume → Δ MS, seizures

## Key hormones

• **Antidiuretic hormone (ADH):** primary hormone that regulates _sodium concentration_

_Stimuli:_ hyperosmolality (290–295 mOsm), ↓↓ effective arterial volume, angiotensin II

_Action:_ insertion of aquaporin-2 channels in principal cells → passive water reabsorption

urine osmolality is an indirect functional assay of the ADH-renal axis

Uosm range: 50 mOsm/L (no ADH) to 1200 mOsm/L (maximal ADH)

• **Aldosterone:** primary hormone that regulates _total body sodium_ (and ∴ volume)

_Stimuli for secretion:_ hypovolemia (via renin and angiotensin II), hyperkalemia

_Action:_ iso-osmotic principal cell reabsorption of Na via epithelial Na channel (ENaC) in exchange for K+ or H+

# HYPONATREMIA

## 病生理 
> (_JASN_ 2008;19:1076; _NEJM_ 2015;372:1349)

• Free water clearance (CH²O) = solute (intake) excretion/Uosm normal dietary solute load ~750 mOsm/d, minimum Uosm = 50 mOsm/L → excrete ~15 L

• **Excess H****2****O relative to Na**, usually due to ↑ **ADH**

• ↑ ADH may be _appropriate_ (eg, hypovolemia or hypervolemia with ↓ EAV)

• ↑ ADH may be _inappropriate_ (SIADH)

• Rarely, ↓ ADH (appropriately suppressed), but kidneys unable to maintain 正常 \[Na\]serum

↑ _H2O intake (1_° _polydipsia):_ ingestion of massive quantities (usually >15 L/d) of free H2O overwhelms diluting ability of kidney → H2O retention

↓ solute intake (“tea & toast” & beer potomania_):_ ↓↓ daily solute load → insufficient solute to excrete H2O intake (eg, if only 250 mOsm/d, minimum Uosm = 50 mOsm/L → excrete in ~5 L; if H2O ingestion exceeds this amount → H2O retention)

## Workup 
> (_JASN_ 2012;23:1140 & 2017;28:1340; _Crit Care_ 2013;17:206; _NEJM_ 2015;372:55)

• **History:** (1) acute vs. chronic (>48 h); (2) sx severity; (3) risk for neuro complications (alcoholism, malnourished, cirrhosis, older females on thiazides, hypoxia, hypoK)

• Measure **plasma osmolality**

_Hypotonic (Posm_ <_280)_ most common scenario; true excess of free H2O relative to Na

_Isotonic (Posm 280_–_295):_ rare lab artifact from hyperlipidemia or hyperproteinemia

_Hypertonic (Posm_ >_295):_ excess of another effective osmole (eg, glucose, mannitol) that draws H2O intravascularly; for each 100 mg/dL ↑ glc >100 mg/dL → ↓ \[Na\] by ~2 mEq/L

• For hypotonic hyponatremia, ✔ **volume status** (JVP, skin turgor, dry axilla, mucous membranes, edema, ascites), effusions, vital signs, orthostatics, BUN/Cr, FEUricAcid, UNa

• Measure **U****osm**, although useful for dx in limited circumstances, b/c almost always >300

Uosm <100 in ↑ H2O intake (1o polydipsia) or ↓ solute intake (beer potomania, “tea & toast”)

Uosm >300 does not mean SIADH; must determine if ↑ ADH appropriate or inappropriate

however, Uosm can be important when deciding on _治療_ (see below)

• If euvolemic and ↑ Uosm, evaluate for glucocorticoid insufficiency and hypothyroidism

• If available, consider FEUricAcid as >12% suggests SIADH (_J Clinc Endo_ 2008;93:2991)

### Figure 4-4 Approach to hyponatremia

![](images/00067.jpeg)

## Hypovolemic hypotonic hyponatremia 
> (ie, ↓↓ total body Na, ↓ TBW)

• **Renal losses** (UNa >20 mEq/L, FENa >1%): diuretics (esp. thiazides, because loop diuretics

↓ tonicity of medullary interstitium, Δ for H2O absorption, & ∴ urine concentrating ability), salt-wasting nephropathy, cerebral salt wasting, mineralocorticoid deficiency

• **Extrarenal losses** (UNa <10 mEq/L, UCl <10 mEq/L if alkalemia, FENa <1%): hemorrhage, GI loss (diarrhea or vomiting), third-spacing (pancreatitis), ↓ PO intake, insensible losses

## Euvolemic hypotonic hyponatremia 
> (ie, ↑ TBW relative to total body Na)

• **SIADH** (euvolemia or mild hypervolemia, typically **inapprop Uosm** >**100,** UNa >20 mEq/L)

**Malignancy:** lung (SCLC), brain, GI, GU, lymphoma, leukemia, thymoma, mesothelioma

**Pulmonary:** pneumonia, TB, aspergillosis, asthma, COPD, PTX, mechanical ventilation

**Intracranial:** trauma, stroke, SAH, seizure, infxn, hydrocephalus, Guillain-Barré

**Drugs:** antipsychotics, antidepress. (SSRI, TCA, MAOi), haloperidol, chemo (vincristine, cisplatin), AVP, MDMA, NSAIDs, opiates, amiodarone (_Am J Kidney Dis_ 2008;52:144)

**Miscellaneous:** pain, nausea, postoperative state

• **Endocrinopathies:** ↑ ADH activity seen in _glucocorticoid deficiency_ (co-secretion of ADH & CRH) and _severe hypothyroidism/myxedema coma_ (↓ CO/SVR → ADH release & ↓ GFR)

• **Psychogenic polydipsia** (Uosm <100, ↓ FEUric Acid): usually intake >15 L/d

• **Low solute** (↓ UNa, ↓ Uosm) “tea & toast”; beer potomania

• Reset osmostat: chronic malnutrition (↓ intracellular osmoles) or pregnancy (hormonal

effects) → ADH physiology reset to regulate a lower \[Na\]serum

## Hypervolemic hypotonic hyponatremia (ie, ↑ total body Na, ↑ ↑ TBW)

• ↓ EAV → ↑ RAAS → ↑ aldosterone & ↑ adrenergic tone → ↑↑ ADH (_Am J Med_ 2013;126:S1)

• **CHF** (↓ CO & renal venous congestion → ↓ EAV; UNa <10 mEq/L, FENa <1%)

• **Cirrhosis** (splanchnic arterial vasodilation + ascites → ↓ EAV; UNa <10 mEq/L, FENa <1%)

• **Nephrotic syndrome** (hypoalbuminemia → edema → ↓ EAV; UNa <10 mEq/L, FENa <1%)

• **Advanced renal failure** (diminished ability to excrete free H2O; UNa >20 mEq/L)

## 治療 
> (_NEJM_ 2015;372:55; _JASN_ 2017;28:1340; _CJASN_ 2018;13:641 & 984)

• **Approach:** depends on _volume status_, _acuity_ of hyponatremia, and if _symptomatic_

Acute sx: _initial_ rapid correction of \[Na\]serum (2 mEq/L/h for the first 2–3 h) until sx resolve

Asx or chronic symptomatic: correct \[Na\]serum at rate of ≤0.5 mEq/L/h

Rate ↑ Na _should not exceed 6_ (chronic) to _8_ (acute) mEq/L/d to avoid central pontine myelinolysis/osmotic demyelination (CPM/ODS: paraplegia, dysarthria, dysphagia)

If severe (<120) or neuro sx: consider 3% NaCl. dDAVP 1-2 µg q8h in consultation with nephrology (to prevent rapid overcorrection) (_AJKD_ 2013;61:571; _CJASN_ 2018; 13:641)

• **Frequent lab draws** and **IVF rate adjustments** are cornerstones of 治療

• **Rapid correction:** can lead to CPM/ODS (esp if chronic or Na <120 mEq/L). Should be emergently reversed with dDAVP ± D5W; partial neuro recovery possible (_CJASN_ 2014;9:229).

• **Effect of IV fluids** ([http://www.medcalc.com/sodium.html](http://www.medcalc.com/sodium.html))

![](images/00068.jpeg)

![](images/00069.jpeg)

_However_, above assumes infusate retained _withoutut output of Na/H2_O; adjust for UOP.  
If Pt euvolemic (eg, SIADH), infused Na will be excreted: for 1 L NS (154 mEq Na or 308 mOsm solute in 1 L H2O); in SIADH with Uosm = 616 → 308 mOsm solute excreted in 0.5 L H2O → net gain 0.5 L H2O → ↓ \[Na\]serum. ∴ NS _worsens_ Na if Uosm > infusateosm.

• **Hypovolemic hyponatremia:** volume repletion with isotonic 0.9% saline at a **slow rate**. Once volume replete → stimulus for ADH removed (w/ very short ADH t½) → kidneys excrete free H2O → serum Na will correct rapidly (D5W ± ddAVP if overcorrection)

• **SIADH** (_NEJM_ 2007;356:2064; _AJKD_ 2015;65:435): **fluid restrict** + treat underlying cause

hypertonic saline (± loop diuretic) if sx or Na fails to ↑ with fluid restriction 1 L hypertonic saline (3% NaCl) will raise \[Na\]serum by ~10 mEq (see above) ~50 mL/h will ↑ \[Na\] by ~0.5 mEq/L/h; 100–200 mL/h will ↑ \[Na\] by ~1–2 mEq/L/h formula only provides estimate; ∴ recheck serum Na frequently (at least q2h)

NaCl tabs if chronic and no CHF. Consider urea 0.25-0.5g/kg/d (_Nephrol Dial Trans_ 2014;29:ii1)

aquaresis: vaptans (vasopressin receptor antag) for refractory SIADH (_NEJM_ 2015;372:23)

demeclocycline: causes nephrogenic DI, ↓ Uosm (rarely used)

• **Hypervolemic hyponatremia:** free water restrict (1st line), diurese with loop diuretics (avoid thiazides) & ↑ EAV (vasodilators to ↑ CO in CHF, colloid infusion in cirrhosis)

vaptans sometimes used; however, no mortality benefit, hypoNa recurs after stopping drug, high risk of overcorrection, contraindicated in cirrhosis (_NEJM_ 2015;372:2207)

# HYPERNATREMIA

## 病生理 
> (_Crit Care_ 2013;17:206; _NEJM_ 2015;372:55)

• Deficit of water relative to sodium; by 定義, all hypernatremic 病人 are hypertonic

• Usually **loss of hypotonic fluid** (ie, “dehydration”); occasionally infusion of hypertonic fluid, post-ATN diuresis with loss of low or electrolyte-free water (_Am J Neph_ 2012;36:97)

• **_And_ impaired access to free water** (eg, intubation, Δ MS, elderly): hypernatremia is a powerful thirst stimulus, ∴ usually only develops in 病人 without access to H2O or ill

## Workup

• ✔ Uosm, UNa, volume status (vital signs, orthostatics, JVP, skin turgor, BUN, Cr)

### Figure 4-5 Approach to hypernatremia

![](images/00070.jpeg)

## Extrarenal H2O loss (Uosm >700–800)

• **GI H2O loss:** vomiting, NGT drainage, osmotic diarrhea, fistula, lactulose, malabsorption

• **Insensible loss:** fever, exercise, ventilation, burns

## Renal H2O loss (Uosm <700–800)

• **Diuresis:** osmotic (glucose, mannitol, urea), loop diuretics

###  Diabetes insipidus
> (_J Clin Endocrinol Metab_ 2012;97:3426)

ADH deficiency (central) or resistance (nephrogenic)

####  **Central:** 
> hypothalamic or posterior pituitary disease (congenital, trauma/surgery, infiltrative/IgG4); also idiopathic, hypoxic/ischemic encephalopathy (shock, Sheehan’s syndrome), anorexia, sarcoidosis, histiocytosis, drugs: EtOH, phenytoin, snake venom

> tumors: craniopharyngioma, germinoma, lymphoma, leukemia, meningioma, pituitary

#### Nephrogenic 
> (_Annals_ 2006;144:186)

congenital (ADH receptor V2 mutation, aquaporin-2 mutation; _Ped Nephrol_ 2012;27:2183)

drugs: **lithium**, amphotericin, demeclocycline, foscarnet, cidofovir, ifosfamide

metabolic: **hypercalcemia**, **severe hypokalemia**, protein malnutrition, congenital

tubulointerstitial: **postobstruction**, **recovery phase of ATN**, PKD, sickle cell, Sjögren’s, amyloid, pregnancy (placental vasopressinase)

DI usually presents as severe polyuria and mild hypernatremia

## Other (Uosm >700–800)

• **Na overload:** hypertonic saline (eg, resuscitation with NaHCO3), mineralocorticoid excess

• **Seizures**, ↑ **exercise:** ↑ intracellular osmoles → H2O shifts → transient ↑ \[Na\]serum

## 治療 (_NEJM_ 2015;372:55)

• **Restore access to H****2****O** or supply daily requirement of H2O (≥1 L/d)

• **Replace free H****2****O deficit** (also replace concurrent volume deficit if appropriate):

![](images/00071.jpeg)

eg, 1 L D5W given to 70-kg man with \[Na\] = 160 mEq/L will ↓ \[Na\]serum by 3.7 mEq

nb, do not forget to correct Na if hyperglycemia also present

• Rate of correction depends on acuity of onset and risk:

chronic (>48 hr): ~12 mEq/d appears safe without risk of cerebral edema (_CJASN_ 2019;14:656)

acute (<48 hr): may ↓ Na by 2 mEq/L/h until Na 145

hyperacute (min-hrs) & life threatening (ICH, seizure): rapidly infuse D5W ± emergent HD

• _Estimate:_ in 70-kg man, 125 mL/h of free H2O will ↓ \[Na\] by ~0.5 mEq/L/h

• ½ NS (77 mEq/L) or ¼ NS (38 mEq/L) provides both volume & free H2O (500 or 750 mL of free H2O per L, respectively); can give free H2O via NGT/OGT

• Formulas provide only estimates; ∴ recheck serum Na frequently

• **DI and osmotic diuresis:** see “Polyuria” section below

• **Na overload:** D5W + diuretic. Consider HD if life threatening (ICH, hypertonia, seizures).

# POLYURIA

## 定義 and 病生理

• **Polyuria** defined as >3 L UOP per day

• Due to an _osmotic_ or a _water diuresis;_ almost always due to osmotic diuresis in inpatients

## Workup

• Perform a timed urine collection (6 h sufficient) and measure Uosm

• 24-h osmole excretion rate = 24-h UOP (actual or estimate) × Uosm

\>1000 mOsm/d → osmotic diuresis; <800 mOsm/d → water diuresis

## Osmotic diuresis

• 原因

Hyperglycemia (>180 exceeds PCT reabsorption), mannitol, propylene glycol

Na: NaCl IVF, recovering AKI (eg, post obstruction)

Urea: ↑ protein feeds, hypercatabolism (burns, steroids), GI bleed, resolving azotemia

## Water diuresis

• 原因: **diabetes insipidus** (DI) (Naserum >143) or **1**° **polydipsia** (Naserum <136)

see “Hypernatremia” above for list of causes of central and nephrogenic DI

• Workup of DI: Uosm <300 (complete) or 300–600 (partial)

>  water deprivation test (start in a.m., ✔ Naserum, Posm, Uosm, UOP q1–2h)

Deprive until Posm >295, then ✔ Uosm. If Uosm <300, then administer vasopressin (5 U SC) or dDAVP (10 mg intranasal), then check Uosm in 1–2 h: Uosm ↑ by >50% = central DI Uosm unchanged = nephrogenic DI

✔ADH level before and after water deprivation to evaluate proper response

Hypertonic saline-stimulated plasma copeptin >4.9 pmoL/L indicates 1° polydipsia (97% accuracy vs. 77% for water deprivation; _NEJM_ 2018;379:428)

### Figure 4-6 Approach to polyuria

![](images/00072.jpeg)

## 治療

• **1° polydipsia:** treat psychiatric illness, check meds, restrict access to free H2O

• **Osmotic diuresis:** address underlying cause, replace free H2O deficit (see “Hypernatremia” for formula to calculate) and ongoing losses

• **DI:**

Central DI: desmopressin (dDAVP, 1st line), low Na/protein diet + HCTZ, chlorpropamide

Nephrogenic DI: treat underlying cause if possible; Na restriction + HCTZ (mild volume depletion → ↓ delivery of filtrate for free H2O absorption), consider amiloride for Li-induced DI (_Kid Int_ 2009;76:44), indomethacin (_NEJM_ 1991;324:850) or trial desmopression

Pregnancy-induced DI: due to vasopressinase from placenta, ∴ Rx with dDAVP
